Men’s Sexual Health & STI Guide: Testing, Prevention & Care

When time matters: PEP and acute symptoms

HIV post-exposure prophylaxis (PEP) is emergency prevention after a possible exposure. CDC says it must be started within 72 hours, and every hour matters. If prescribed, the course is taken daily for 28 days. Contact an urgent-care service, emergency department or an appropriate sexual-health service immediately rather than waiting to see whether symptoms appear. [4]

Examples worth urgent assessment include a condom break or another recent exposure where HIV transmission may be possible, and sexual assault. A clinician assesses whether PEP is indicated; this page cannot determine your individual exposure risk. A test taken immediately after exposure cannot by itself rule out an infection acquired in that encounter. [4]

Sudden severe testicular pain requires emergency assessment because a time-sensitive non-STI problem such as torsion is possible. Fever with significant genital or urinary symptoms, severe pain or rapidly worsening illness also calls for prompt care. Do not assume that every genital symptom is an STI or that a mail-order antibiotic is appropriate. [8]

Outside the United States, use local emergency and sexual-health services. If immediate safety is a concern after assault or violence, seek a safe place and urgent professional help.

What to tell the clinician—without labels doing the guessing

Describe the types of contact, relevant body sites, condom or barrier use, when exposure occurred, any symptoms and whether a partner has a known infection. Include prior STI results, treatment, HIV prevention medicines and vaccination history. These details help choose the right specimens and timing. [1]

• You can say: “I have had oral and anal sex; do I need throat or rectal swabs as well as urine or blood tests?”
• Ask what confidentiality protections apply and whether results, billing or electronic messages could be seen by someone else.
• If talking with your usual clinician feels difficult, consider a dedicated sexual-health clinic.
• Tell the service about pregnancy possibilities for partners when relevant to prevention or treatment advice.

Sexual orientation and relationship status do not identify every exposure. A respectful clinician can explain why a question matters, and you can ask for privacy or clarification. The aim is an accurate care plan, not a moral judgment. [1]

Specimen sites: what urine, swabs and blood each contribute

Follow the particular kit or laboratory instructions. A home test may be useful, but it does not replace examination when there are significant symptoms or urgent concerns. CDC distinguishes self-testing, which produces a result at home, from self-collection sent to a laboratory; their scope and next steps can differ. [1]

A positive screening result may need confirmation or additional assessment depending on the infection and test. Ask who will arrange that next step. A result without a follow-up pathway is not a complete service. [1]

How often should men be tested?

CDC’s March 2026 patient guidance recommends at least one HIV test for everyone ages 13–64. It advises at least annual testing for syphilis, chlamydia and gonorrhea for sexually active gay and bisexual men and men who have sex with men, with more frequent testing—such as every three to six months—for relevant increased risk. HIV testing may also need to be more frequent. [1]

For heterosexual men at low risk, CDC’s screening table describes insufficient evidence for routine chlamydia and gonorrhea screening, with consideration in some high-prevalence settings. That does not mean symptoms, a partner’s diagnosis or a specific exposure should be ignored. Population screening and testing a clinical concern are different decisions. [3]

CDC’s current patient page also emphasizes syphilis testing according to local epidemiology. Your care plan should reflect where you live, partners and practices, prior infections and prevention medicines. Do not convert a population table into a claim that everyone needs every test monthly—or that anyone is exempt from testing. [1] [3]

Agree a repeat date and how changes in partners or exposure would alter it. The right interval can change over time. A dated negative result describes what that test could detect then; it is not an ongoing protection or a guarantee about another person.

Testing windows: a negative result can be too early

Different infections and different test methods have different detection windows. A test soon after an encounter may not settle whether infection was acquired then. Ask the clinician which result is interpretable now and whether later repeat testing is needed. This guide does not offer one universal “all clear after X days” rule. [1] [4]

Do not postpone urgent PEP assessment while waiting for a test window. Similarly, symptoms or a partner’s positive result can require assessment before the date of your next routine screen. Tell the clinician about any antibiotics or HIV prevention medicines because they may affect the testing and follow-up plan. [1] [4] [5]

Avoid comparing results from two different test types as though they have identical timing and meaning. Keep a copy of the actual report, including date and test name, and ask for an explanation of an unclear or indeterminate result.

Questions to leave the testing visit with

• Which infections and body sites were tested today?
• Which exposure dates can these tests reasonably address?
• Is a repeat or confirmatory test needed, and who arranges it?
• How will results be communicated privately?
• What symptoms or new exposures should prompt earlier contact?

A negative report is not ongoing protection. Follow the clinician’s test-specific plan rather than using one internet window for every infection.

Prevention is layered—not one product or one promise

Condoms used correctly and consistently, appropriate vaccination, partner testing and communication can reduce risk. STIs can spread through oral, anal and vaginal sex and genital skin contact, so no single barrier strategy removes every possibility of infection. Ask about practical use, suitable barriers and the infections relevant to your exposures. [2]

Discuss hepatitis B and HPV vaccination according to eligibility, previous doses and current recommendations. Vaccines do not replace testing or treatment of an existing infection. Bring records rather than assuming that a general childhood vaccination history answers every adult prevention question. [2]

A mutually monogamous relationship with a partner who has been appropriately tested and does not have an STI can reduce risk, but relationship labels alone do not establish test status. Discuss results and expectations directly, without treating a diagnosis as proof of recent infidelity. [2] [7]

PrEP: prevention for HIV, not every STI

Pre-exposure prophylaxis (PrEP) is medicine for people without HIV who may be exposed through sex or injection drug use. It can be provided as pills or injections depending on the appropriate option. It requires a clinical plan, appropriate testing and adherence to the prescribed regimen. [5]

PrEP does not prevent other STIs or pregnancy. Do not skip relevant site-specific STI testing because you use it, and do not share another person’s tablets. If you miss treatment or think a recent exposure was not covered, ask urgently whether additional assessment or PEP is needed. [4] [5]

Choices and availability can change. This guide deliberately does not provide an on-demand schedule, drug selection or dosing instructions. Ask which option is appropriate for your exposure pattern, health and ability to attend follow-up. [5]

Doxy PEP is for a defined discussion—not routine antibiotics for everyone

CDC’s August 2026 patient page recommends that clinicians discuss the benefits and risks of doxy PEP with gay and bisexual men and transgender women who have had chlamydia, syphilis or gonorrhea in the previous 12 months. Evidence supports reduction of certain bacterial STIs in the studied groups; that is not evidence for universal use after every encounter. [6]

Doxy PEP is different from HIV PEP and PrEP. It does not prevent HIV and does not replace other prevention or STI screening. Antimicrobial resistance and longer-term effects are important concerns, which is why the population and follow-up matter. [6]

Do not take leftover antibiotics, combine regimens or copy a friend’s prescription. A clinician should assess suitability, interactions, adverse effects and monitoring. This page is an evidence-and-safety explanation, not a doxycycline dosing protocol. [6]

After a positive result: treatment, partners and follow-up

Ask which infection was identified, what treatment is prescribed, whether further testing is needed and when sex can safely resume under the relevant instructions. Complete the prescribed treatment and follow the specific advice for that infection; do not assume one waiting period or antibiotic applies to all STIs. [7]

Partners may need assessment and treatment even when they feel well. CDC recommends retesting three months after gonorrhea or chlamydia treatment because reinfection is common. This later retest is not the same question as an earlier test of cure, which is required only in particular circumstances under clinical guidance. [7]

A diagnosis can produce strong emotions, but it does not reliably establish who acquired an infection first or when. Ask the clinic about partner-notification support, especially if direct disclosure could create a safety risk. Prompt, nonjudgmental care helps both health and communication. [7]

For erection or desire concerns without an infection diagnosis, use the ED guide or low libido guide. Return to the men’s health overview for the wider care map.

How this guide was researched

Editorial update: October 19, 2026. Key guideline, public-health and safety statements were rechecked against the linked sources during this update. This remains an AI-assisted educational synthesis with no independent medical review; it is not an exhaustive literature search or individualized care.

AI-assisted editorial synthesis of public CDC patient guidance and selected screening-table recommendations, with no independent clinician review. We checked the 2026 testing, PrEP and doxy PEP pages and distinguish them from older underlying treatment recommendations. This is not a comprehensive STI treatment manual, an individual exposure assessment or a self-prescribing protocol. HIV PEP is time-sensitive and should not be delayed for an online guide.

Sources checked October 18, 2026. Medical information can change. This is general education, not diagnosis or individualized treatment. For urgent symptoms use local emergency or urgent-care services.

Sources and evidence notes

1. CDC: Getting Tested for STIs (March 2026). Public overview of testing frequency, specimen sites and self-testing.
2. CDC: How to Prevent STIs (public CDC guidance). Transmission, vaccination, condom use and partner testing guidance.
3. CDC: STI Screening Recommendations. Relevant exposure- and population-specific recommendations inspected; this table references treatment guidelines and original sources of different dates.
4. CDC: Preventing HIV with PEP. Emergency timing and 28-day prescribed course guidance.
5. CDC: Preventing HIV with PrEP (September 2026). Public prevention overview and limitations; this guide does not prescribe a regimen.
6. CDC: Preventing STIs with Doxy PEP (August 2026). Eligible discussion groups, evidence boundaries and antimicrobial-resistance concerns inspected.
7. CDC: Next steps after testing positive for gonorrhea or chlamydia. Partner care and three-month retesting information.
8. NHS: Testicle pain. Urgent symptom guidance; use local emergency pathways outside the UK.